Sana Biotechnology prices $75M public offering of common stock and pre-funded warrants

Sana Biotechnology, Inc.

Priced 20,895,522 shares at $3.35/share and 1,492,537 pre-funded warrants at $3.3499/underlying share.
Gross proceeds expected ~$75M, net proceeds ~$70M after underwriting discounts and expenses.
Underwriters granted 30-day option to purchase up to 3,358,208 additional shares.
Offering expected to close August 8, 2025; Morgan Stanley, Goldman Sachs, BofA, TD Cowen lead.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.